At a concentration of 90 U/mL, heparin can decrease cTnI concentrations by approximately 20% because of binding interactions that reduce immunoreactivity; conversely, the decline in cTnT levels is caused by interactions between negatively charged glycosaminoglycan and basic amino acid residues.